Mayo Clinic Ventures

Submit a New Inquiry

Technology #2013-237 - Methods of Using PD1 Antibodies to Treat Cancer by Detecting Bim Expression Levels

Mayo Clinic Ventures contracts with Nouvant to provide this service.

Your inquiry will be sent to this technology's managers. All fields are required unless otherwise noted.



By submitting this inquiry you accept the terms of the Privacy Policy and Terms of Service.

Powered by Nouvant